Skip to main content

Nerve Decompression May Ease Painful Diabetic Peripheral Neuropathy

Medically reviewed by Carmen Pope, BPharm. Last updated on March 28, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, March 28, 2024 -- For patients with lower-extremity painful diabetic peripheral neuropathy (DPN), nerve decompression is associated with reduced pain, although these effects may be partly due to a placebo effect, according to a study published online Feb. 8 in the Annals of Surgery.

Shai M. Rozen, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues examined the effect of nerve decompression on pain in patients with lower-extremity painful DPN. Patients aged 18 to 80 years with lower-extremity painful DPN were randomly assigned to receive nerve decompression or observation in a 2:1 ratio. Decompression group patients were further randomly assigned to receive nerve decompression in either the right or left leg and sham surgery in the opposite leg (22 and 18 patients in the right- and left-decompression groups, respectively).

The researchers found that compared with the 37 controls, the right- and left-decompression groups reported significantly lower pain (mean difference for both, −4.46) at 12 months. Equal improvement was seen in decompressed and sham legs. Compared with 14 controls, at 56 months, pain was significantly lower in the right-decompression group (20 patients) and left-decompression group (16 patients; mean differences, −7.65 and −7.26, respectively). In the decompressed versus sham legs, the mean pain score was significantly lower (mean difference, 1.57).

"The current data does not provide definitive evidence for benefit of surgical decompression in painful diabetic peripheral neuropathy," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted March 2024

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.